LYNETTE EWUCHIE: Open Payments
NPI 1881010130 · WAXAHACHIE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,159 in 33 payments from 7 companies in 2025. Trend: 2023 $1,224 · 2024 $625 · 2025 $1,159
Food & beverage: $1,159
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $330 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $215 |
| Otsuka America Pharmaceutical, Inc. | 7 | $197 |
| ABBVIE INC. | 12 | $165 |
| Axsome Therapeutics, Inc. | 1 | $119 |
| Janssen Pharmaceuticals, Inc | 1 | $110 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
Products named: CAPLYTA, AUSTEDO XR, REXULTI, VRAYLAR, Auvelity, UZEDY, INVEGA SUSTENNA, COBENFY.
Industry payments across TX — which companies pay providers there.
